Neutrophil Gelatinase Associated Lipocalin (NGAL) for Identification of Unstable Plaques in Patients with Asymptomatic Carotid Stenosis.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 01 03 2018
accepted: 26 12 2018
pubmed: 6 6 2019
medline: 10 7 2019
entrez: 6 6 2019
Statut: ppublish

Résumé

Neutrophil gelatinase associated lipocalin (NGAL) and matrix metalloproteinase (MMP)-9/NGAL complex were investigated in asymptomatic patients with carotid artery stenosis including gender specific differences aiming at vulnerable plaques prone to embolisation. Serum NGAL and MMP-9/NGAL levels were analysed in 83 patients with asymptomatic carotid artery stenosis. Pre-operative ultrasound and post-endarterectomy histology of carotid atherosclerotic lesions were evaluated. Patients with vulnerable plaques, as determined by ultrasound (plaques with decreased echogenicity) and histological analysis (type VI according to the classification of the American Heart Association), displayed the highest levels of NGAL and MMP-9/NGAL complex (p = .0003 and p = .0078, respectively). Grade VI plaques were primarily detected in patients with "soft" plaques (12 type VI plaques in 25 patients), but also in patients with mixed (four of 19) and calcified (three of 39) plaques according to ultrasound. Higher grade carotid artery stenosis (≥90%) was not associated with elevated NGAL levels. The receiver operating characteristic curve analysis detecting grade VI lesions yields an area under the curve (AUC) = 0.85, with respect to soft plaque on ultrasound the AUC = 0.86. There were no gender specific differences in levels of NGAL 80.9 (37.7) ng/mL in women vs. 76.7 (36.3) ng/mL in men, p = .607) nor of MMP-9/NGAL 33.0 (18.2-55.5) ng/mL in women vs. 36.7 (20.2-54.0) ng/mL in men, p = .969. Likewise, there were no gender associated differences in vulnerable plaque characteristics: either for grade VI plaques (17.9% vs. 27.3%, p = .582) or for the presence of soft plaques as evaluated by ultrasound (35.9% vs. 25%, p = .503). Circulating NGAL and MMP-9/NGAL are significantly increased in asymptomatic patients with vulnerable carotid atherosclerotic plaques independent of gender. Accordingly, serum NGAL may be proposed as a valuable biomarker for the detection of unstable carotid plaques in asymptomatic patients, who can then be selected for early carotid endarterectomy or stenting.

Identifiants

pubmed: 31164272
pii: S1078-5884(19)30001-2
doi: 10.1016/j.ejvs.2018.12.029
pii:
doi:

Substances chimiques

Biomarkers 0
LCN2 protein, human 0
Lipocalin-2 0
MMP9 protein, human EC 3.4.24.35
Matrix Metalloproteinase 9 EC 3.4.24.35

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

768-777

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.

Auteurs

Wolf Eilenberg (W)

Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria.

Stefan Stojkovic (S)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria.

Alexandra Kaider (A)

Centre for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Austria.

Aleksandra Piechota-Polanczyk (A)

Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.

Josif Nanobachvili (J)

Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria.

Christoph M Domenig (CM)

Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria.

Johann Wojta (J)

Department of Internal Medicine II, Division of Cardiology, Medical University of Vienna, Austria; Core Facilities, Medical University of Vienna, Vienna, Austria.

Ihor Huk (I)

Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria.

Svitlana Demyanets (S)

Department of Laboratory Medicine, Medical University of Vienna, Austria.

Christoph Neumayer (C)

Department of Surgery, Division of Vascular Surgery, Medical University of Vienna, Austria. Electronic address: christoph.neumayer@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH